Scholarly Article
Parental Evaluation of Botulinum Toxin Therapy in Children with Cerebral Palsy: A Cross-Sectional Study from Western Libya and Its Clinical Implications
Fayrouz Abu Alasad, Einass Ragab, Wafa Alshaiby
2026-01-03 · AlQalam Journal of Medical and Applied Sciences · University of Tripoli Alahlia
Abstract
Cerebral palsy (CP) is a common childhood motor disorder caused by non-progressive brain injury or malformation during early development, leading to muscle spasticity and coordination problems. This cross-sectional study aims to evaluate parental satisfaction with botulinum toxin type A BoNT-A) treatment in children with cerebral palsy, focusing on perceived effectiveness and side effects. The study's objectives include collecting demographic and clinical information, assessing parental knowledge of BoNT-A, evaluating treatment outcomes, monitoring side effects, and measuring overall patient satisfaction. The study involved 75 children aged 1 to 5 years, mostly affected by birth-related oxygen deprivation. Data collected from parents showed significant improvements in muscle tone and daily activities following BoNT-A treatment, with most parents expressing positive satisfaction despite some mild side effects. The findings suggest that BoNT-A is a safe and helpful treatment when combined with rehabilitation therapies. This study highlights the importance of educating parents about BoNT-A treatment and emphasizes the need for careful patient selection and follow-up to achieve optimal results. Increasing awareness among healthcare providers and families can improve treatment experiences for children with cerebral palsy.
Keywords
Cerebral Palsy, Botulinum Toxin, Spasticity, Parental Evaluation, Libya
Citation Details
AlQalam Journal of Medical and Applied Sciences, Vol. 9, No. 1, pp. 1-4